|
|
|
Saturday, March 24, 2007 - 7:00 PM, Elizabeth H
|
- Pulmonary Pathology of Transplantation
|
|
Moderator:
|
Michael Fishbein, David Geffen School of Medicine, Los Angeles, CA
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. Charles C. Marboe indicated he is a consultant for XDX, Inc., South San Francisco, CA. All other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to download handout in 1-per-page format for the entire meeting
Click here to download handout in 6-per-page format for the entire meeting
Click any blue title below to display and print the handout for individual lecture(s):
| 7:00 | Pathology of Lung Transplantation - Charles C. Marboe, Columbia University, New York, NY |
| 7:45 | Pulmonary Pathology Associated With Bone Marrow and Other Solid Organ Transplantation - Kevin O. Leslie, Mayo Medical School, Scottsdale, AZ |
| 8:15 | Clinical Approaches to Lung Transplantation and Other Transplant Organs - Robert M. Aris, University of North Carolina, Chapel Hill, NC |
| The Program committee is responsible for making decisions regarding topics for the symposium. Thoughts are solicited from the entire society. These recommendations are first presented to the Executive Board and then to the full membership for approval. The goals of this program are: 1) Present the new classification of acute and chronic rejection of the lung allograft proposed by ISHLT. 2) describe the morphologic manifestations of lung injury in non-pulmonary allografts focusing primarily on graft versus host disease. 3) Provide a clinician's perspective on management of lung transplant recipients and other recipients of allograft organs. |
|
|
|
